BROOKS — Brooks Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹2.80bn
- IN₹2.84bn
- IN₹632.05m
Annual cashflow statement for Brooks Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -149 | -135 | -89.9 | -239 | -354 |
| Depreciation | |||||
| Non-Cash Items | 27.4 | 51.1 | 31.5 | 37.2 | 26.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 6.55 | -76.3 | 31.6 | -246 | 112 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -50.5 | -93.9 | 44.6 | -374 | -145 |
| Capital Expenditures | -8.67 | -25.8 | -56.1 | -232 | -4.67 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 19.8 | 2.58 | 4.84 | -16.9 | 9.62 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 11.2 | -23.3 | -51.3 | -249 | 4.95 |
| Financing Cash Flow Items | -30.5 | -33.9 | -30.2 | 713 | 154 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 57.8 | 96.1 | 11.6 | 641 | 114 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 18.5 | -21 | 4.88 | 17.2 | -25.8 |